(Q39660484)

13 September 2017

title

Wilms' tumour protein Wt1 stimulates transcription of the gene encoding vascular endothelial cadherin (English)

1 reference

13 September 2017

0 references

Lina Katrin Sciesielski

series ordinal

2

1 reference

13 September 2017

Karin M Kirschner

1

1 reference

13 September 2017

Holger Scholz

series ordinal

3

1 reference

13 September 2017

language of work or name

1 reference

2 September 2010

1 reference

13 September 2017

1 reference

13 September 2017

volume

460

1 reference

13 September 2017

issue

6

1 reference

13 September 2017

page(s)

1051-1061

1 reference

Epicardium-derived cells contribute a novel population to the myocardial wall and the atrioventricular cushions

13 September 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00424-010-0873-6

The Wilms' tumor suppressor Wt1 is expressed in the coronary vasculature after myocardial infarction.

21 January 2018

1 reference

12 December 2020

Breaking the VE-cadherin bonds.

1 reference

12 December 2020

High level of endothelial cell-specific gene expression by a combination of the 5' flanking region and the 5' half of the first intron of the VE-cadherin gene

1 reference

12 December 2020

The Wilms' tumour suppressor WT1 is involved in endothelial cell proliferation and migration: expression in tumour vessels in vivo

1 reference

12 December 2020

Wt1 is required for cardiovascular progenitor cell formation through transcriptional control of Snail and E-cadherin.

1 reference

12 December 2020

Transcriptional regulation by WT1 in development.

1 reference

12 December 2020

Angiogenesis and vascular targeting in Ewing sarcoma: a review of preclinical and clinical data

1 reference

12 December 2020

Isoforms of Wilms' tumor suppressor gene (WT1) have distinct effects on mammary epithelial cells

1 reference

12 December 2020

The Wilms tumor suppressor gene wt1 is required for development of the spleen.

1 reference

12 December 2020

Subnuclear localization of WT1 in splicing or transcription factor domains is regulated by alternative splicing

1 reference

12 December 2020

Wilms' tumour: connecting tumorigenesis and organ development in the kidney

1 reference

12 December 2020

Targeted null-mutation in the vascular endothelial-cadherin gene impairs the organization of vascular-like structures in embryoid bodies

1 reference

12 December 2020

WT-1 is required for early kidney development

1 reference

12 December 2020

WT1 expression in angiogenic tumours of the skin.

1 reference

12 December 2020

WT1 suppresses synthesis of the epidermal growth factor receptor and induces apoptosis

1 reference

12 December 2020

WT1-mediated gene regulation in early urogenital ridge development.

1 reference

12 December 2020

The candidate Wilms' tumour gene is involved in genitourinary development

1 reference

12 December 2020

YAC complementation shows a requirement for Wt1 in the development of epicardium, adrenal gland and throughout nephrogenesis

1 reference

12 December 2020

A splice variant of the Wilms' tumour suppressor Wt1 is required for normal development of the olfactory system

1 reference

12 December 2020

Role of vascular endothelial-cadherin in vascular morphogenesis

1 reference

12 December 2020

The expression of the Wilms' tumour gene, WT1, in the developing mammalian embryo.

1 reference

12 December 2020

1 reference

12 December 2020

Tumor blood vessels formation in osteosarcoma: vasculogenesis mimicry.

1 reference

12 December 2020

The cellular basis of kidney development

1 reference

12 December 2020

Embryonic development of the proepicardium and coronary vessels

1 reference

12 December 2020

The Wilms' tumor gene Wt1 is required for normal development of the retina

1 reference

12 December 2020

Cell adhesion dynamics at endothelial junctions: VE-cadherin as a major player

1 reference

12 December 2020

Hypoxia-inducible Factor-1 (HIF-1) Is a Transcriptional Activator of theTrkBNeurotrophin Receptor Gene

1 reference

12 December 2020

CD144 (VE-cadherin) is transiently expressed by fetal liver hematopoietic stem cells

1 reference

12 December 2020

Tumor-induced upregulation of Twist, Snail, and Slug represses the activity of the human VE-cadherin promoter.

1 reference

12 December 2020

Comparative promoter analysis allows de novo identification of specialized cell junction-associated proteins

1 reference

12 December 2020

The Wilms' tumor suppressor Wt1 activates transcription of the erythropoietin receptor in hematopoietic progenitor cells

1 reference

12 December 2020

The Wilms tumor suppressor Wt1 promotes cell adhesion through transcriptional activation of the alpha4integrin gene

1 reference

12 December 2020

Inactivation of WT1 in nephrogenic rests, genetic precursors to Wilms' tumour

1 reference

12 December 2020

Wilms tumor suppressor, Wt1, is a transcriptional activator of the erythropoietin gene

1 reference

12 December 2020

Coronary vessel development requires activation of the TrkB neurotrophin receptor by the Wilms' tumor transcription factor Wt1.

1 reference

12 December 2020

The post-transcriptional roles of WT1, a multifunctional zinc-finger protein

1 reference

12 December 2020

cDNA cloning, chromosomal mapping, and expression analysis of human VE-Cadherin-2.

1 reference

12 December 2020

Alternative splicing and genomic structure of the Wilms tumor gene WT1

1 reference

12 December 2020

The human VE-cadherin promoter is subjected to organ-specific regulation and is activated in tumour angiogenesis

1 reference

12 December 2020

10.1007/S00424-010-0873-6

Identifiers

DOI

1 reference

13 September 2017

1 reference